deoxycytidine has been researched along with Mycosis Fungoides in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Assaf, C; Blazejak, C; Gambichler, T; Gosman, J; Klemke, CD; Nicolay, JP; Olk, J; Stadler, R; Stendel, S; Stranzenbach, R; Wehkamp, U; Weyermann, M; Wobser, M | 1 |
| Bianchi, L; Cantonetti, M; Di Raimondo, C; Meconi, F; Monopoli, A; Narducci, MG; Nunzi, A; Rapisarda, V; Scala, E; Tesei, C; Vaccarini, S; Zizzari, A | 1 |
| Duvic, M; Oki, Y; Wilmas, K | 1 |
| Assaf, C; Nicolay, JP | 1 |
| Desai, N; Goff, HW; Rizvi, S; Stewart, JR; Zhu, H | 1 |
| Beyer, M; Erdmann, R; Humme, D; Nast, A; Vandersee, S | 1 |
| Duvic, M | 1 |
| Amoh, Y; Masuzawa, M; Takasu, H | 1 |
| Abramovici, O; Carlos Molano, L; Cuvelier, A; Darmon, A; Duval-Modeste, AB; Louvel, JP; Muir, JF; Piton, N | 1 |
| Agostinelli, C; Grandi, V; Patrizi, A; Pellegrini, C; Pileri, A; Pimpinelli, N; Zinzani, PL | 1 |
| Bertsch, HP; Buhl, T; Kaune, KM; Kretschmer, L; Mitteldorf, C; Schön, MP | 1 |
| Argnani, L; Baccarani, M; Broccoli, A; Derenzini, E; Fina, M; Gandolfi, L; Pellegrini, C; Pileri, S; Quirini, F; Stefoni, V; Venturini, F; Zinzani, PL | 1 |
| Karoopongse, E; Pattanaprichakul, P; Siriphukpong, S; Sitthinamsuwan, P | 1 |
| Anliker, M; Bargetzi, M; Itin, P; Weder, P | 1 |
| Anadolu, RY; Birol, A; Erdem, C; Sanli, H; Türsen, U | 1 |
| Apisarnthanarax, N; David, CL; Duvic, M; Kurzrock, R; Talpur, R; Wen, S | 1 |
| Awar, O; Duvic, M | 1 |
| Albertini, P; Bendandi, M; Gherlinzoni, F; Magagnoli, M; Orcioni, GF; Pileri, SA; Tura, S; Zinzani, PL | 1 |
| Ascani, S; Baliva, G; Bendandi, M; Gherlinzoni, F; Magagnoli, M; Modugno, G; Orcioni, GF; Pileri, SA; Simoni, R; Tura, S; Zinzani, PL | 1 |
5 review(s) available for deoxycytidine and Mycosis Fungoides
| Article | Year |
|---|---|
[Treatment of mycosis fungoides and Sézary syndrome].
Topics: Adrenal Cortex Hormones; Bexarotene; Brentuximab Vedotin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Immunoconjugates; Interferon-alpha; Mycosis Fungoides; Neoplasm Recurrence, Local; Neoplasm Staging; Phototherapy; Polyethylene Glycols; PUVA Therapy; Sezary Syndrome; Skin Neoplasms; World Health Organization | 2017 |
Alemtuzumab is an effective third-line treatment versus single-agent gemcitabine or pralatrexate for refractory Sézary syndrome: a systematic review.
Topics: Alemtuzumab; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Deoxycytidine; Folic Acid Antagonists; Gemcitabine; Humans; Mycosis Fungoides; Retreatment; Sezary Syndrome; Skin Neoplasms | 2018 |
Systematic review of combination therapies for mycosis fungoides.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Combined Modality Therapy; Deoxycytidine; Ficusin; Gemcitabine; Humans; Hydroxamic Acids; Interferon-alpha; Methotrexate; Mycosis Fungoides; Phototherapy; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes; Vorinostat | 2014 |
[Gemcitabine Monotherapy for Advanced Mycosis Fungoides--Two Case Reports and a Literature Review].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Mycosis Fungoides; Prednisone; Skin Neoplasms; Vincristine | 2015 |
Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Drug Administration Schedule; Drug Resistance, Neoplasm; Gemcitabine; Humans; Infusions, Intravenous; Male; Mycosis Fungoides; Skin Neoplasms; Treatment Outcome | 2007 |
4 trial(s) available for deoxycytidine and Mycosis Fungoides
| Article | Year |
|---|---|
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Deoxycytidine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, T-Cell; Male; Middle Aged; Mycosis Fungoides; Recurrence; Skin Neoplasms; Time Factors; Treatment Outcome | 2010 |
Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Receptors, Interleukin-2; Sezary Syndrome; Skin Neoplasms; Treatment Outcome | 2006 |
Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Neutropenia; PUVA Therapy; Remission Induction; Safety; Salvage Therapy; Thrombocytopenia; Treatment Outcome | 1998 |
Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Skin Neoplasms; Survival Rate | 2000 |
10 other study(ies) available for deoxycytidine and Mycosis Fungoides
| Article | Year |
|---|---|
Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network.
Topics: Breast Neoplasms; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2022 |
Continuous low-dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study.
Topics: Deoxycytidine; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Retrospective Studies; Sezary Syndrome; Skin Neoplasms | 2022 |
Atypical lymphoproliferative disorder-clinical and pathological features.
Topics: Aged; Antineoplastic Agents; Deoxycytidine; Depsipeptides; Female; Gemcitabine; Humans; Lymphoproliferative Disorders; Mycosis Fungoides; Radiotherapy; Skin Neoplasms | 2016 |
Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome.
Topics: Alemtuzumab; Aminopterin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Clinical Trials as Topic; Deoxycytidine; Depsipeptides; Diphtheria Toxin; Disease Progression; Doxorubicin; Electrons; Gemcitabine; Humans; Hydroxamic Acids; Immunotherapy; Incidence; Interleukin-2; Lenalidomide; Lymphoma, T-Cell; Mycosis Fungoides; Pentostatin; Photopheresis; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Retinoids; Sezary Syndrome; Stem Cell Transplantation; Thalidomide; United States; Vorinostat | 2015 |
[Chronic alveolar condensations with erythematous cutaneous lesions].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Deoxycytidine; Diagnosis, Differential; Doxorubicin; Erythema; Female; Gemcitabine; Humans; Lung Neoplasms; Mycosis Fungoides; Pulmonary Alveoli; Skin Neoplasms; Vidarabine | 2016 |
Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dermatitis, Exfoliative; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Humans; Lymphadenopathy; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Organoplatinum Compounds; Prednisolone; Prednisone; Sezary Syndrome; Vincristine | 2017 |
Low-dose gemcitabine efficacious in three patients with tumor-stage mycosis fungoides.
Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Mycosis Fungoides; Skin Neoplasms | 2009 |
Granulomatous mycosis fungoides with large cell transformation misdiagnosed as leprosy.
Topics: Antimetabolites, Antineoplastic; Cell Transformation, Neoplastic; Deoxycytidine; Diagnostic Errors; Disease Progression; Gemcitabine; Granuloma; Humans; Leprosy; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Weakness; Mycosis Fungoides; Skin Neoplasms; Treatment Outcome | 2010 |
Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Mycosis Fungoides; Ribonucleotide Reductases; Skin Neoplasms | 2004 |
Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Child; Deoxycytidine; Female; Gemcitabine; Humans; Interferon-alpha; Male; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Pentostatin; PUVA Therapy; Sezary Syndrome; Treatment Outcome | 2005 |